Autek China Past Earnings Performance

Past criteria checks 2/6

Autek China has been growing earnings at an average annual rate of 15.8%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 21.4% per year. Autek China's return on equity is 13.8%, and it has net margins of 35.2%.

Key information

15.8%

Earnings growth rate

14.4%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate21.4%
Return on equity13.8%
Net Margin35.2%
Next Earnings Update29 Mar 2025

Recent past performance updates

Recent updates

Is Autek China (SZSE:300595) A Risky Investment?

Jan 07
Is Autek China (SZSE:300595) A Risky Investment?

A Look At The Fair Value Of Autek China Inc. (SZSE:300595)

Dec 24
A Look At The Fair Value Of Autek China Inc. (SZSE:300595)

Is Autek China Inc. (SZSE:300595) Potentially Undervalued?

Nov 11
Is Autek China Inc. (SZSE:300595) Potentially Undervalued?

Autek China (SZSE:300595) Might Be Having Difficulty Using Its Capital Effectively

Oct 14
Autek China (SZSE:300595) Might Be Having Difficulty Using Its Capital Effectively

Autek China Inc.'s (SZSE:300595) Shares Climb 44% But Its Business Is Yet to Catch Up

Sep 30
Autek China Inc.'s (SZSE:300595) Shares Climb 44% But Its Business Is Yet to Catch Up

Autek China Inc. (SZSE:300595) Shares Could Be 49% Below Their Intrinsic Value Estimate

Sep 01
Autek China Inc. (SZSE:300595) Shares Could Be 49% Below Their Intrinsic Value Estimate

Little Excitement Around Autek China Inc.'s (SZSE:300595) Earnings

Aug 14
Little Excitement Around Autek China Inc.'s (SZSE:300595) Earnings

Be Wary Of Autek China (SZSE:300595) And Its Returns On Capital

Jul 04
Be Wary Of Autek China (SZSE:300595) And Its Returns On Capital

Autek China (SZSE:300595) Has Announced That It Will Be Increasing Its Dividend To CN¥0.223

May 14
Autek China (SZSE:300595) Has Announced That It Will Be Increasing Its Dividend To CN¥0.223

We Think Autek China (SZSE:300595) Can Manage Its Debt With Ease

Apr 16
We Think Autek China (SZSE:300595) Can Manage Its Debt With Ease

An Intrinsic Calculation For Autek China Inc. (SZSE:300595) Suggests It's 28% Undervalued

Mar 22
An Intrinsic Calculation For Autek China Inc. (SZSE:300595) Suggests It's 28% Undervalued

Autek China Inc.'s (SZSE:300595) 25% Price Boost Is Out Of Tune With Earnings

Mar 04
Autek China Inc.'s (SZSE:300595) 25% Price Boost Is Out Of Tune With Earnings

There Are Reasons To Feel Uneasy About Autek China's (SZSE:300595) Returns On Capital

Mar 01
There Are Reasons To Feel Uneasy About Autek China's (SZSE:300595) Returns On Capital

Revenue & Expenses Breakdown

How Autek China makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300595 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,84965156440
30 Jun 241,84068055041
31 Mar 241,80068652641
31 Dec 231,73766749940
30 Sep 231,63465746939
30 Jun 231,62167644336
31 Mar 231,55664942433
01 Jan 231,52562443034
30 Sep 221,51061741632
30 Jun 221,40955739231
31 Mar 221,37956537429
01 Jan 221,29555535127
30 Sep 211,26059932826
30 Jun 211,14456129724
31 Mar 211,05453327422
31 Dec 2087143323819
30 Sep 2076935521819
30 Jun 2068131820718
31 Mar 2063029419617
31 Dec 1964730719416
30 Sep 1961328018716
30 Jun 1954724916615
31 Mar 1950223114913
31 Dec 1845821612413
30 Sep 184192049912
30 Jun 183661768115
31 Mar 183311606613
31 Dec 173121516210
30 Sep 17288140496
30 Jun 17258124480
31 Mar 17249122480
31 Dec 16235114460
31 Dec 1517689380
31 Dec 1413064310

Quality Earnings: 300595 has high quality earnings.

Growing Profit Margin: 300595's current net profit margins (35.2%) are lower than last year (40.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300595's earnings have grown by 15.8% per year over the past 5 years.

Accelerating Growth: 300595's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 300595 had negative earnings growth (-0.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).


Return on Equity

High ROE: 300595's Return on Equity (13.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 06:36
End of Day Share Price 2025/01/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Autek China Inc. is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Yichi ZhangChina International Capital Corporation Limited
Bin WuChina Merchants Securities Co. Ltd.